<DOC>
	<DOCNO>NCT00501618</DOCNO>
	<brief_summary>The purpose study obtain data equivalence generic clozapine Fazaclo ( orally disintegrate tablet ) . Generic clozapine frequently use clozapine data important clinician .</brief_summary>
	<brief_title>Equivalence Generic Clozapine Orally Dissolving Clozapine Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description>The primary objective study determine equivalence generic clozapine tablet FazaClo patient schizophrenia schizoaffective disorder already take generic clozapine switch FazaClo . In study , patient receive stable twice-daily dose generic clozapine formulation past one month switch FazaClo . A trough steady-state clozapine desmethylclozapine concentration take thrice patient generic Clozapine . After third clozapine level patient switch generic clozapine formulation FazaClo , dosage treatment regimen generic clozapine formulation receiving . Trough steady-state clozapine desmethylclozapine concentration level take twice , 7 day 14 day start Fazaclo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>Patients ( male female ) 18 59 year age . Female patient pregnant breastfeed surgically sterilize , postmenopausal ( least six month ) , sexually abstinent use adequate contraceptive method ( define diaphragm , condom , foam/jellies , sponge , and/or oral contraceptive ) . Patients diagnosis 1 ) treatmentresistant schizophrenia ; 2 ) schizophrenia , chronic ( type ) residual phase remission , schizoaffective disorder accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) criterion judge chronic risk reexperiencing suicidal behavior base history recent clinical state . In addition , patient must total score PANSS 90 less . Patients generic clozapine formulation one month prior Visit 1 change clozapine psychotropic medication dosage past one month . Clozapine dose administer twice daily . Patients clinically significant abnormality medical history , physical examination , clinical laboratory test . Patients give write consent advised nature risk study competent sign Informed Consent Form . Patients show inconsistent clozapine plasma level inconsistent clinical response therapeutically adequate daily dose clozapine document medical chart document nursing note patient ' cheek oral tablet clozapine least 6 month . Patients include National NonRechallenge Master File Clozaril . Patients medical surgical condition might interfere absorption , metabolism , excretion clozapine FazaClo . Patients history granulocytopenia myeloproliferative disorder , either druginduced idiopathic . Patients total white blood cell ( WBC ) count 4000/mm3 absolute neutrophil count ( ANC ) 2000/mm3 . Patients history clinically significant cardiovascular , renal , hepatic , respiratory , endocrine ( except noninsulindependent diabetes mellitus ) , gastrointestinal disease . Patients known history human immunodeficiency virus infection . Patients history epilepsy seizure comatose experience severe central nervous system depression . Patients unable communicate investigator . Patients history allergic reaction clozapine chemically relate psychotropic drug . Patients concurrent primary psychiatric neurological diagnosis , include organic mental disorder ( DSMIV criterion ) , mental retardation , severe tardive dyskinesia , idiopathic Parkinson 's disease . Patients electroconvulsive therapy within past three month . Patients demonstrate clinically significant homicidal behavior within past 12 month . Patients receive investigational drug within past 30 day . Patients history narrowangle glaucoma . Patients require treatment drug know interact clozapine ( e.g. , agent wellknown potential suppress bonemarrow functioning , drug highly proteinbound , cimetidine , phenytoin ) . Clozapine may also potentiate effect antihypertensives anticholinergic ; therefore , caution take patient receive drug enrol study . Patients morbidly obese ( define body mass index [ BMI ] great 40 ; BMI = weight [ kg ] /height [ m2 ] ) . Patients known history phenylketonuria . FazaClo contain aspartame , source phenylalanine harmful patient phenylketonuria .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>Orally dissolve clozapine</keyword>
	<keyword>orally disintegrate clozapine</keyword>
	<keyword>bio-equivalence</keyword>
	<keyword>desmethylclozapine</keyword>
	<keyword>clozapine plasma level</keyword>
	<keyword>equivalence</keyword>
	<keyword>fazaclo</keyword>
	<keyword>generic clozapine</keyword>
</DOC>